cetuximab,encorafenib
pfizer,merck,eli lilly
['colorectal', 'breakwater', 'lba26', 'rectal', 'pfizer']
see updated safety, pharmacokinetics and antitumor activity data from the ongoing phase 3 breakwater study evaluating a brafi and egfri combination with or without chemotherapy in patients with metastatic brafv600e colorectal cancer #esmo22 lba26 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ